Guru Ownership Trend
Guru Analysis for Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.64 M.
Top institutional holders include Paul Tudor Jones and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.56 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 13.0%. Conversely, Cliff Asness reduced exposure by 28.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Amylyx Pharmaceuticals, Inc. (AMLX)
Major holders include Paul Tudor Jones ($635,964), Cliff Asness ($373,909). According to the latest reported data, 2 tracked investment managers collectively hold approximately 56,229 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.56 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited AMLX. The total reported sell value was $1.63 M.
Yes, 0 managers opened new positions in AMLX, and 1 increased their existing holdings. The total reported buy value was $73,205.01.